Skip to main content
Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0
I suspect a merge with WLA will do much for cash flows as Lipitor co payments seemed to be at the base of the delayed collection. The real question is will the combined R&D structure be successful and cost effective. You don't hear much of WLA's Agouran purchase and associated pipeline, which I think holds great promise. BWJ
Print the post  

Announcements

When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.